InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Kiniksa Pharmaceuticals International, plc

KNSA Clue Score67
Fiscal year ends December CIK 0001730430 Results filed 27 Oct 2026
Add to watchlist

What the insiders did Mostly scheduled

Individual transactions

85
Insider
Date
Role
Action
Shares
Price
Amount
Sanj K Patel
3 Nov 2026
Chairman & CEO
Sold after exercise indirect
4,584
$94.25
$432.04K
Sanj K Patel
3 Nov 2026
Chairman & CEO
Sold after exercise indirect
145,708
$93.53
$13.63M
Sanj K Patel
3 Nov 2026
Chairman & CEO
Sold after exercise indirect
68,664
$92.70
$6.37M
Sanj K Patel
3 Nov 2026
Chairman & CEO
Sold after exercise indirect
1,214
$90.77
$110.19K
Ross Moat
2 Nov 2026
Chief Operating Officer
Sold after exercise
722
$94.05
$67.90K
Ross Moat
2 Nov 2026
Chief Operating Officer
Sold after exercise
11,642
$93.15
$1.08M
Ross Moat
2 Nov 2026
Chief Operating Officer
Sold after exercise
8,932
$92.05
$822.19K
Ross Moat
2 Nov 2026
Chief Operating Officer
Sold after exercise
6,681
$91.23
$609.51K
John F. Paolini
2 Nov 2026
Chief Medical Officer
Sold after exercise
704
$94.09
$66.24K
John F. Paolini
2 Nov 2026
Chief Medical Officer
Sold after exercise
16,810
$93.42
$1.57M
John F. Paolini
2 Nov 2026
Chief Medical Officer
Sold after exercise
899
$92.37
$83.04K
Mark Ragosa
2 Nov 2026
Chief Financial Officer
Sold after exercise
220
$94.01
$20.68K
Mark Ragosa
2 Nov 2026
Chief Financial Officer
Sold after exercise
12,034
$93.13
$1.12M
Mark Ragosa
2 Nov 2026
Chief Financial Officer
Sold after exercise
10,502
$92.03
$966.50K
Mark Ragosa
2 Nov 2026
Chief Financial Officer
Sold after exercise
14,027
$91.40
$1.28M
Sanj K Patel
2 Nov 2026
Chairman & CEO
Sold after exercise indirect
100
$93.97
$9.40K
Sanj K Patel
2 Nov 2026
Chairman & CEO
Sold after exercise indirect
26,781
$93.06
$2.49M
Sanj K Patel
2 Nov 2026
Chairman & CEO
Sold after exercise indirect
24,188
$91.83
$2.22M
Sanj K Patel
2 Nov 2026
Chairman & CEO
Sold after exercise indirect
38,364
$91.03
$3.49M
Michael R Megna
30 Oct 2026
Chief Accounting Officer
Sold after exercise
5,350
$97.74
$522.91K
Michael R Megna
30 Oct 2026
Chief Accounting Officer
Sold after exercise
1,691
$97.11
$164.21K
Michael R Megna
30 Oct 2026
Chief Accounting Officer
Sold after exercise
3,145
$96.08
$302.17K
Michael R Megna
30 Oct 2026
Chief Accounting Officer
Sold after exercise
3,705
$94.86
$351.46K
Michael R Megna
30 Oct 2026
Chief Accounting Officer
Sold after exercise
9,508
$94.20
$895.65K
Michael R Megna
30 Oct 2026
Chief Accounting Officer
Sold after exercise
6,831
$92.77
$633.71K
Michael R Megna
30 Oct 2026
Chief Accounting Officer
Sold after exercise
6,030
$91.87
$553.98K
Ross Moat
30 Oct 2026
Chief Operating Officer
Sold after exercise
2,575
$97.76
$251.73K
Ross Moat
30 Oct 2026
Chief Operating Officer
Sold after exercise
1,760
$97.10
$170.90K
Ross Moat
30 Oct 2026
Chief Operating Officer
Sold after exercise
3,672
$96.03
$352.62K
Ross Moat
30 Oct 2026
Chief Operating Officer
Sold after exercise
6,282
$94.92
$596.29K
Ross Moat
30 Oct 2026
Chief Operating Officer
Sold after exercise
8,430
$93.97
$792.17K
Ross Moat
30 Oct 2026
Chief Operating Officer
Sold after exercise
15,114
$92.81
$1.40M
Ross Moat
30 Oct 2026
Chief Operating Officer
Sold after exercise
37,775
$92.00
$3.48M
John F. Paolini
30 Oct 2026
Chief Medical Officer
Sold after exercise
2,155
$97.77
$210.69K
John F. Paolini
30 Oct 2026
Chief Medical Officer
Sold after exercise
1,925
$97.06
$186.84K
John F. Paolini
30 Oct 2026
Chief Medical Officer
Sold after exercise
4,000
$95.97
$383.88K
John F. Paolini
30 Oct 2026
Chief Medical Officer
Sold after exercise
4,821
$94.86
$457.32K
John F. Paolini
30 Oct 2026
Chief Medical Officer
Sold after exercise
6,841
$93.91
$642.44K
John F. Paolini
30 Oct 2026
Chief Medical Officer
Sold after exercise
16,056
$92.85
$1.49M
John F. Paolini
30 Oct 2026
Chief Medical Officer
Sold after exercise
41,789
$92.02
$3.85M
Sanj K Patel
30 Oct 2026
Chairman & CEO
Sold after exercise indirect
1,440
$98.16
$141.35K
Sanj K Patel
30 Oct 2026
Chairman & CEO
Sold after exercise indirect
2,316
$97.34
$225.44K
Sanj K Patel
30 Oct 2026
Chairman & CEO
Sold after exercise indirect
4,490
$95.97
$430.91K
Sanj K Patel
30 Oct 2026
Chairman & CEO
Sold after exercise indirect
8,888
$94.72
$841.87K
Sanj K Patel
30 Oct 2026
Chairman & CEO
Sold after exercise indirect
15,903
$93.62
$1.49M
Sanj K Patel
30 Oct 2026
Chairman & CEO
Sold after exercise indirect
18,685
$92.77
$1.73M
Sanj K Patel
30 Oct 2026
Chairman & CEO
Sold after exercise indirect
41,169
$92.01
$3.79M
Michael R Megna
3 Sep 2026
Chief Accounting Officer
Sold on a plan
4,600
$80.30
$369.38K
G Bradley Cole
29 Jul 2026
Director
Sell
3,673
$81.43
$299.09K
Sanj K Patel
1 May 2026
Chairman & CEO
Sold after exercise
48,565
$54.02
$2.62M
John F. Paolini
1 May 2026
Chief Medical Officer
Sold after exercise
21,097
$54.04
$1.14M
John F. Paolini
1 May 2026
Chief Medical Officer
Sold after exercise
37,327
$53.52
$2.00M
Sanj K Patel
30 Apr 2026
Chairman & CEO
Sold after exercise
2,141
$54.01
$115.64K
Sanj K Patel
29 Apr 2026
Chairman & CEO
Sold after exercise
22,544
$54.01
$1.22M
Barry D Quart
28 Apr 2026
Director
Sold after exercise
13,099
$50.10
$656.26K
Sanj K Patel
28 Apr 2026
Chairman & CEO
Sold after exercise
51,750
$54.02
$2.80M
Sanj K Patel
28 Apr 2026
Chairman & CEO
Sold after exercise
243,596
$52.02
$12.67M
Sanj K Patel
28 Apr 2026
Chairman & CEO
Sold after exercise
113,673
$51.47
$5.85M
Sanj K Patel
28 Apr 2026
Chairman & CEO
Sold after exercise
74,635
$50.43
$3.76M
Ross Moat
9 Apr 2026
Chief Operating Officer
Sold on a plan
1,703
$46.69
$79.51K
Michael R Megna
9 Apr 2026
Chief Accounting Officer
Sold on a plan
6,625
$46.69
$309.32K
Michael R Megna
7 Apr 2026
Chief Accounting Officer
Exercised, kept
3,932
$1.00
$3.93K
Barry D Quart
6 Apr 2026
Director
Sold after exercise
6,901
$50.00
$345.05K
Ross Moat
6 Apr 2026
Chief Operating Officer
Sold on a plan
2,367
$48.58
$114.99K
Sanj K Patel
6 Apr 2026
Chairman & CEO
Sold after exercise
7,278
$50.01
$363.97K
Mark Ragosa
9 Mar 2026
Chief Financial Officer
Sold after exercise
18,741
$46.24
$866.58K
Mark Ragosa
9 Mar 2026
Chief Financial Officer
Sold after exercise
17,981
$45.58
$819.57K
John F. Paolini
2 Mar 2026
Chief Medical Officer
Sold after exercise
5,714
$45.92
$262.39K
John F. Paolini
2 Mar 2026
Chief Medical Officer
Sold after exercise
22,223
$44.88
$997.37K
John F. Paolini
2 Mar 2026
Chief Medical Officer
Sold after exercise
12,063
$44.20
$533.18K
Barry D Quart
12 Feb 2026
Director
Sold after exercise
2,690
$45.00
$121.05K
Barry D Quart
10 Feb 2026
Director
Sold after exercise
110
$45.00
$4.95K
Mark Ragosa
9 Feb 2026
Chief Financial Officer
Sold after exercise
8,731
$43.72
$381.72K
Mark Ragosa
9 Feb 2026
Chief Financial Officer
Sold after exercise
9,114
$42.85
$390.53K
Barry D Quart
4 Feb 2026
Director
Sold after exercise
2,602
$45.02
$117.14K
Barry D Quart
3 Feb 2026
Director
Sold after exercise
12,528
$45.27
$567.14K
Barry D Quart
2 Feb 2026
Director
Sold after exercise
830
$45.00
$37.35K
Mark Ragosa
8 Jan 2026
Chief Financial Officer
Sold on a plan
12,000
$41.89
$502.68K
Eben Tessari
15 Dec 2025
Chief Operating Officer
Sold after exercise
12,048
$41.56
$500.71K
Barry D Quart
15 Dec 2025
Director
Sold after exercise
20,129
$41.51
$835.55K
Mark Ragosa
8 Dec 2025
Chief Financial Officer
Sold after exercise
42,841
$41.49
$1.78M
Eben Tessari
26 Nov 2025
Chief Operating Officer
Sold after exercise
200
$42.89
$8.58K
Eben Tessari
17 Nov 2025
Chief Operating Officer
Sold after exercise
11,825
$41.30
$488.37K
Eben Tessari
17 Nov 2025
Chief Operating Officer
Sold after exercise
645
$40.08
$25.85K
Mark Ragosa
12 Nov 2025
Chief Financial Officer
Sold after exercise
19,900
$40.94
$814.71K

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 78
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 2,865,665
History held since 29 May 2018